Lineage Cell Therapeutics In shares owned by Fort Sheridan Advisors
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Fort Sheridan Advisors
from 13F filings
Historical chart of Fort Sheridan Advisors investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Fort Sheridan Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Fort Sheridan Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $99k | 84k | 1.18 |
| 2023-06-30 | $118k | 84k | 1.41 |
| 2023-03-31 | $111k | 74k | 1.50 |
| 2022-12-31 | $98k | 84k | 1.17 |
| 2022-09-30 | $95k | 84k | 1.13 |
| 2022-06-30 | $125k | 79k | 1.58 |
| 2022-03-31 | $117k | 76k | 1.54 |
| 2021-12-31 | $130k | 53k | 2.46 |
| 2021-09-30 | $121k | 48k | 2.52 |
| 2021-06-30 | $137k | 48k | 2.86 |
| 2021-03-31 | $106k | 45k | 2.36 |